C. Gattringer

1.1k total citations
45 papers, 939 citations indexed

About

C. Gattringer is a scholar working on Immunology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, C. Gattringer has authored 45 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Pathology and Forensic Medicine and 11 papers in Hematology. Recurrent topics in C. Gattringer's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). C. Gattringer is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). C. Gattringer collaborates with scholars based in Austria, United States and Germany. C. Gattringer's co-authors include H. Huber, Johannes Drach, Saili Zhao, Michael Andreeff, Doris Drach, H Braunsteiner, J. Thaler, Richard Greil, Andreas Widschwendter and Christian Marth and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Clinical Cancer Research.

In The Last Decade

C. Gattringer

42 papers receiving 902 citations

Peers

Countries citing papers authored by C. Gattringer

Since Specialization

Citations

This map shows the geographic impact of C. Gattringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gattringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gattringer more than expected).

Fields of papers citing papers by C. Gattringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Gattringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gattringer. The network helps show where C. Gattringer may publish in the future.

Co-authorship network of co-authors of C. Gattringer

This figure shows the co-authorship network connecting the top 25 collaborators of C. Gattringer. A scholar is included among the top collaborators of C. Gattringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Gattringer. C. Gattringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie 2008 ·DMW - Deutsche Medizinische Wochenschrift ·J. Thaler, Thomas Kühr, Günther Gastl, H. Huber, C. Gattringer, Dietger Niederwieser, (unknown), (unknown), Georg Kemmler, H. L. Seewann, K Abbrederis, Alois Lang, H. Gadner, (unknown), Irving W. Schiller, H. Hausmaninger, Raimund Weitgasser, (unknown), Michael Fridrik, Carina Huber	0
2	Analysis of Aberrant DNA Methylation and Human Papillomavirus DNA in Cervicovaginal Specimens to Detect Invasive Cervical Cancer and Its Precursors 2004 ·Clinical Cancer Research ·Andreas Widschwendter, C. Gattringer, Lennart Ivarsson, Heidi Fiegl, (unknown), A Ramoni, Hannes Müller, Annemarie Wiedemair, (unknown), Elisabeth Müller‐Holzner, Hans H. Goebel, Christian Marth, Martin Widschwendter	63
3	Cell profiles in serial bronchoalveolar lavage after human heart-lung transplantation. 1992 ·PubMed ·(unknown), (unknown), C. Gattringer, (unknown), R. Margreiter	5
4	Direct demonstration of binding of aggregated mouse IgG1 to the 40-kDa Fc receptor for IgG (FcγRII) in both high and low responders 1992 ·Immunology Letters ·Johannes Möst, H. Glassl, C. Gattringer, (unknown), Thomas F. Schulz, M P Dierich, H. Huber	4
5	Surface immunoglobulin density in the differential diagnosis of B-cell chronic lymphocytic leukemia and leukemic immunocytoma 1992 ·Leukemia Research ·Christof Ludescher, C. Gattringer, (unknown), Johannes Drach, J. Thaler, (unknown), H. Huber	4
6	Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group. 1992 ·PubMed ·R Zittoun, (unknown), Franco Mandelli, Bruno Rotoli, (unknown), C. Gattringer, L Resegotti, Francesco Paolo Caronia, Pietro Leoni, Petti Mc	8
7	Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments] 1992 ·Blood ·Doris Drach, Saili Zhao, Johannes Drach, (unknown), C. Gattringer, H. Huber, Michael Andreeff	278
8	Non-Hodgkin's lymphoma of the lung diagnosed by gene rearrangement from bronchoalveolar lavage fluid: a fast and noninvasive method [letter] 1991 ·Blood ·(unknown), C. Prior, Katharina Weyrer, Florian Umlauft, C. Gattringer, K Grünewald, Martin Tötsch, Falko Fend	13
9	Continuous Infusion of Mitoxantrone Combined with High-Dose Cytarabine in Refractory/Relapsed Acute Myeloblastic Leukemia and Blast Crisis of Chronic Myelogenous Leukemia 1990 ·Hämatologie und Bluttransfusion ·Werner Linkesch, J. Thaler, C. Gattringer, G Konwalinka	2
10	Multiple myeloma with coexpression of myeloid and natural killer cell antigens [letter] 1990 ·Blood ·Johannes Drach, C. Gattringer, H. Huber	9
11	GM-CSF Treatment in Aplasia after Cytotoxic Therapy 1989 ·Oncology Research and Treatment ·C. Gattringer, J. Thaler, Johannes Drach, M. Micksche, Heidemarie Huber	7
12	Diagnostic and prognostic value of immunohistological bone marrow examination: Results in 212 patients with lymphoproliferative disorders 1987 ·Annals of Hematology ·J. Thaler, H. Denz, C. Gattringer, H. Glassl, Monika Lechleitner, Otto Dietze, H. Huber	24
13	Immunologische Markeruntersuchungen bei malignen Lymphomen: Diagnostische und prognostische Relevanz 1986 ·Oncology Research and Treatment ·Hanna Huber, J. Thaler, Richard Greil, C. Gattringer, T. Radaszkiewicz	1
14	Macrophage infiltration in non-Hodgkin'S lymphomas: A quantitative in situ study 1986 ·Immunobiology ·Monika Lechleitner, C. Gattringer, Guenther Gastl, (unknown), Walter Pfaller, F. Schmalzl, H. Huber	4
15	Surface glycoproteins (S-GP) on normal and malignant human leukocytes 1985 ·Annals of Hematology ·(unknown), Rudolf Pfister, D. Lutz, (unknown), Helmut Gadner, C. Gattringer, F. Schmalzl, H Braunsteiner, Ch. Huber	2
16	Infiltration density of HNK1 positive cells in non-hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis 1985 ·Immunobiology ·C. Gattringer, T Radaszkiewicz, Walter Pfaller, H. Huber	5
17	Follow-up Studies on Proliferative T Cell Responses in Cadaveric Kidney Graft Recipients under Combined Immunosuppressive Treatment with Cyclosporine and Prednisone 1985 ·Immunobiology ·Eveline U. Irschick, Dietger Niederwieser, (unknown), M Spielberger, C. Gattringer, R. Margreiter, Christian G. Huber	1
18	Large granular lymphocytes: Morphological and functional properties I. Results in normals 1983 ·Annals of Hematology ·Günther Gastl, F. Schmalzl, D. Huhn, C. Gattringer, Christian G. Huber	7
19	[In vitro studies of clonable human B lymphocytes]. 1983 ·PubMed ·Christian Peschel, C. Gattringer, James Boyd, D. Geißler, H. Huber, G Konwalinka	0
20	Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes. 1982 ·The Journal of Experimental Medicine ·C. Huber, Matthias Merkenschlager, C. Gattringer, Ivor Royston, U. Fink, H Braunsteiner	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact